Table 1.
Participant demographics and baseline data summarised by trial arm as analysed (ITT)
| Variable | Enterosgel (n=43) | Control (n=43) |
| Age in years, mean (SD) | 44.0 (14.2) | 43.3 (14.5) |
| Age in years, median (IQR) | 44 (32–55) | 46 (31–56) |
| Sex: male, n (%) | 22 (51) | 22 (51) |
| Ethnicity, n (%) | ||
| White | 41 (95) | 39 (91) |
| Asian British | 0 (0) | 3 (7) |
| Black/African/Caribbean/Black British | 0 (0) | 1 (2) |
| Mixed | 1 (2) | 0 (0) |
| Other | 1 (2) | 0 (0) |
| Diarrhoea duration in hours*, mean (SD) | 138.6 (138.3) | 115.9 (139.5) |
| Diarrhoea duration in hours*, median (IQR) | 96 (41–186) | 77 (50–134) |
| Symptoms†, n (%) | ||
| Nausea | 21 (50) | 21 (49) |
| Vomiting | 10 (24) | 12 (28) |
| Fever (≥38°C) | 7 (16) | 21 (49) |
| Abdominal pain | 37 (86) | 30 (70) |
| Potential sources of infection, n (%) | ||
| Travel | 9 (21) | 6 (14) |
| Other contact | 6 (14) | 8 (19) |
| Food poisoning | 7 (17) | 4 (9) |
| Use of medication‡, n (%) | 9 (21) | 7 (16) |
Listing for each group: age, sex, ethnicity, diarrhoea duration prior to randomisation (hours), symptoms (experienced prior to randomisation), potential sources of infection and use of any medication/treatment for the diarrhoea episode prior to randomisation.
*Duration of diarrhoea symptoms prior to randomisation (hours).
†Experienced prior to randomisation.
‡Use of any medication/treatment for the diarrhoea episode prior to randomisation.
ITT, intention-to-treat.